2020
DOI: 10.1080/14760584.2020.1775080
|View full text |Cite
|
Sign up to set email alerts
|

Vaccine adherence: the rate of hesitancy toward childhood immunization in Kazakhstan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 11 publications
1
9
0
Order By: Relevance
“…But in univariate analysis, we found that age was statistically significant. Furthermore, similar to other studies ( Akhmetzhanova et al., 2020 ; Montalti et al., 2021 ), the channels to access vaccines information affected parents' willingness to vaccination. Supplementary Materials Table 1 analyzed the differences of different age groups accessing vaccines information ( p < 0.001).…”
Section: Discussionsupporting
confidence: 80%
“…But in univariate analysis, we found that age was statistically significant. Furthermore, similar to other studies ( Akhmetzhanova et al., 2020 ; Montalti et al., 2021 ), the channels to access vaccines information affected parents' willingness to vaccination. Supplementary Materials Table 1 analyzed the differences of different age groups accessing vaccines information ( p < 0.001).…”
Section: Discussionsupporting
confidence: 80%
“…Trust in the healthcare system and providers is the third theme in uencing the parental perception of childhood vaccination. Several previous studies have shown that healthcare providers are considered the primary and more in uential source of vaccination information, and people who trust the local healthcare agencies and staff are more likely to be vaccine-con dent [20,34,35]. Our study has identi ed that parents question the skills and knowledge of the medical workers and the quality of the vaccines purchased by the government.…”
Section: Discussionmentioning
confidence: 91%
“…69.5% participants in our study were hesitant to take vaccine since it's a new and immediate vaccine development with shorter development timeline and received emergency approval from WHO for its use in public. 16 Participants also believed that the vaccine developed were for the benefit of pharmaceutical companies and for political gain and thus hesitated.…”
Section: Resultsmentioning
confidence: 99%